In a new report by Transparency Market Research, a definitive analysis of factors that are governing an exponential growth of the global DNA vaccines market is presented. The report looks into the current market trends, industry drivers, and challenges of the DNA vaccines market based on which projections are made for the coming years. The report is titled “DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019.”
Get a Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1584
It also presents an analysis of recent technological developments, Porter’s five force analysis, and competitive profiles of top industry players. In addition, a review of micro and macro parameters that are significant for established and new market entrants along with insights into the market’s value chain is included herein.
The report states that the global DNA vaccines market is displaying an impressive growth due to a host of advantages that this new generation of vaccines presents. DNA vaccines have fewer side effects as compared to conventional vaccines. With an extremely robust pipeline, several new products are expected to receive approval over the report’s forecast period. This will provide significant momentum to the global DNA vaccines market.
Vaccines have been long used as an important and effective way for the prevention of infectious diseases. A conventional vaccine is a biological preparation that contains parts of microbes or whole microbes that have been weakened or killed to prevent the disease from appearing. When an individual is vaccinated with these preparations, the immune system attacks the harmless version of these germs and clears them from the body in no time. However, in turn, the body remembers the pathogens so that in the instance of an encounter with the real virulent germs later in life, the body fights them off with the preserved memory against the particular pathogen.
On the other hand, DNA vaccines are composed of genetically engineered DNA so that cells directly release an antigen for a protective immunological response. When a DNA vaccine is administered into an organism’s cells, it stimulates the organism’s immune system to produce an immunological response against the encoded antigens. DNA vaccines offer numerous advantages over conventional ones. For instance, when a conventional vaccine is injected, it produces an immune response only against an antibody reaction, whereas a DNA vaccine triggers antibody and cell mediated reaction.
The global DNA vaccines market is divided into the segments of animal DNA vaccines and human DNA vaccines. Presently, there are no certified DNA vaccines to be used on humans, however, more than 100 variants are under clinical trials for a host of diseases such as cancer, HIV infection, and other infectious diseases. For example, Inovio Pharmaceuticals has developed the Syncon brand of vaccines for clinical trials for a few types of cancers and infectious diseases.
Some top companies that operate in the global DNA vaccines market are Novartis Animal Health, Merck & Co., Astellas Pharma, Sanofi, Inovio Biomedical Corp., Dendreon Corporation, Vical, and Tekmira Pharmaceuticals.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.Editor's Details
Last updated on: 27/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.